Cargando…

The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry

BACKGROUND: The Ankylosing Spondylitis (AS) Disease Activity Score (ASDAS) is largely used for assessing disease activity in patients with AS. OBJECTIVES: We aimed to investigate the predictability of ASDAS on drug survival in patients with low Bath AS Disease Activity Index (BASDAI) during biologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jinhyun, Kim, Min Jung, Oh, Geun Young, Lee, Sun Kyung, Kim, Taeeun, Shin, Kichul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563457/ https://www.ncbi.nlm.nih.gov/pubmed/37822329 http://dx.doi.org/10.1177/1759720X231201714

Ejemplares similares

Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
por: Jung, Ju-Yang, et al.
Publicado: (2023)

KOBIO, the First Web-based Korean Biologics Registry Operated With a Unified Platform Among Distinct Disease Entities
por: Kim, Jinhyun, et al.
Publicado: (2021)

Implications of Persistent Pain in Patients With Rheumatoid Arthritis Despite Remission Status: Data From the KOBIO Registry
por: Kim, Hyoun-Ah, et al.
Publicado: (2022)

The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis
por: Chen, Yi-Hsing, et al.
Publicado: (2022)

Comparison of Retention Rates Between Tumor Necrosis Factor-α Inhibitors in Patients With Ankylosing Spondylitis: Data From the Korean College of Rheumatology Biologics Registry
por: Kim, Hyoun-Ah, et al.
Publicado: (2021)

Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis
por: Kim, Se Hee, et al.
Publicado: (2021)

Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy
por: Kim, Hyoun-Ah, et al.
Publicado: (2022)

Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry
por: Kim, Seong-Kyu, et al.
Publicado: (2020)

Early achievement of ASDAS clinical response is associated with long-term improvements in metrological outcomes in patients with ankylosing spondylitis treated with TNF-α blockers
por: Nam, Eon Jeong, et al.
Publicado: (2020)

Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score–Matched Analysis from the Korean College of Rheumatology Biologics Registry
por: Kim, Hyoun-Ah, et al.
Publicado: (2020)

Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry
por: Koh, Jung Hee, et al.
Publicado: (2022)

Gastrointestinal risk factors and patient‐reported outcomes of ankylosing spondylitis in Korea
por: Lee, Sang‐Hoon, et al.
Publicado: (2019)

Drug Survival Rates of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
por: Kang, Ji-Hyoun, et al.
Publicado: (2014)

Cost-of-Illness and Quality of Life in Patients with Ankylosing Spondylitis at a Tertiary Hospital in Korea
por: Lee, Tae-Jin, et al.
Publicado: (2014)

Drug survival of tumor necrosis factor α inhibitors in patients with ankylosing spondylitis in Korea
por: Jeong, Hyemin, et al.
Publicado: (2018)

Bath Ankylosing Spondylitis Disease Activity Index is Associated With the Quality of Sleep in Ankylosing Spondylitis Patients
por: Song, Byung Wook, et al.
Publicado: (2021)

Effect of biologics in the level of cytokines in the synovial fluid of patients with ankylosing spondylitis
por: Koo, Bon San, et al.
Publicado: (2020)

Medical Treatment of Ankylosing Spondylitis
por: Moon, Kyoung-Ho, et al.
Publicado: (2014)

Pyogenic Andersson Lesion in a Patient With Ankylosing Spondylitis
por: Kim, Kyung Hoon, et al.
Publicado: (2022)

Are nonsteroidal anti-inflammatory drugs safe for the kidney in ankylosing spondylitis?
por: Kim, Ji-Won
Publicado: (2023)

Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study
por: Proft, Fabian, et al.
Publicado: (2022)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery
por: Nancy, Zaarour, et al.
Publicado: (2021)

Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
por: Lorenzin, Mariagrazia, et al.
Publicado: (2015)

Total ankylosis of the bilateral hand and wrist joints in a patient with ankylosing spondylitis
por: Kim, Shin-Gil, et al.
Publicado: (2021)

The Epidemiology and Treatment of Ankylosing Spondylitis in Korea
por: Kwon, Seong-Ryul, et al.
Publicado: (2022)

Risk factors associated with inadequate control of disease activity in elderly patients with rheumatoid arthritis: Results from a nationwide KOrean College of Rheumatology BIOlogics (KOBIO) registry
por: Jung, Seung Min, et al.
Publicado: (2018)

Pregnancy outcomes in Korean women with ankylosing spondylitis
por: Park, Eun Hye, et al.
Publicado: (2021)

The usefulness of trabecular bone score in patients with ankylosing spondylitis
por: Nam, Seoung Wan, et al.
Publicado: (2021)

Predictive factors of radiographic progression in ankylosing spondylitis
por: Kim, Hyungjin, et al.
Publicado: (2015)

Imaging of ankylosing spondylitis
por: Østergaard, Mikkel
Publicado: (2012)

Alexithymia in ankylosing spondylitis
por: Karabıçak, Deniz, et al.
Publicado: (2021)

A Case of Palisaded Neutrophilic and Granulomatous Dermatitis Associated with an Initial Presentation in Ankylosing Spondylitis
por: Suh, Young Sun, et al.
Publicado: (2023)

Updates on ankylosing spondylitis: pathogenesis and therapeutic agents
por: Kim, Se Hee, et al.
Publicado: (2023)

Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry
por: Michelena, Xabier, et al.
Publicado: (2021)

Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease
por: Jun, Yu Kyung, et al.
Publicado: (2023)

Phlegmonous gastritis in an ankylosing spondylitis patient treated with infliximab
por: Kim, Bo Young, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_31oiq9vetua19op0ivqgb52oca